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Text
In our recent article [1], we did not declare the patent
rights related to stampidine technology. Since they may
potentially be viewed as non-financial competing inter-
ests despite the fact our employer is a non-profit public
charity, we are now providing the following supplemental
information:
FMU, AOV and HET are employees of Parker Hughes
Institute, which has applied for a patent for the use of
stampidine in the treatment of haemorrhagic fever. Parker
Hughes Institute currently holds patents for the use of
stampidine in other clinical conditions, with FMU listed
as an inventor.
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